A Study to Determine Whether EGFR Status by FISH Can Predict Results in Non Small Cell Lung Cancer (NSCLC) Patients Treated With Cetuximab, Carboplatin and Paclitaxel

Clinical trial NCT00768131 · WITHDRAWN

Trial details

NCT number: NCT00768131
Sponsor: Eli Lilly and Company
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Neoplasms Carcinoma, Non-Small-Cell Lung

Start date: 2008-10-01
Primary completion: 2008-10-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.